Novo Nordisk is cutting what Wegovy costs in China, Polskie Radio reports. Tap through for the size of the cut and when it takes effect.
Recap by typeshit. Full story at www.polskieradio.pl.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Semafor reports South Africa has Africa's highest adult obesity rate at 30%, yet branded weight loss drugs remain too expensive for most people there.
Her talk at the Indonesian congress compared tirzepatide's clinical trial results with what doctors see in real-world practice.
Bhekisisa points out that local treatment guidelines now recommend GLP-1s for obesity, while the price keeps them out of reach for many.
Loading…